Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elena Y, Shustova"'
Autor:
Olga E. Ivanova, Tatiana P. Eremeeva, Olga Y. Baykova, Alexandr Y. Krasota, Elizaveta V. Yakovchuk, Elena Y. Shustova, Lyudmila P. Malyshkina, Aida N.-I. Mustafina, Yulia M. Mikhailova, Alina V. Chirova, Evgeniya A. Cherepanova, Nadezhda S. Morozova, Anna S. Gladkikh, Anna S. Dolgova, Vladimir G. Dedkov, Areg A. Totolian, Liubov I. Kozlovskaya
Publikováno v:
Vaccines, Vol 12, Iss 7, p 718 (2024)
The widespread use of the oral poliovaccine from Sabin strains (tOPV) radically reduced poliomyelitis incidence worldwide. However, OPV became a source of neurovirulent vaccine-derived polioviruses (VDPVs). Currently, circulating type 2 VDPVs (cVDPV2
Externí odkaz:
https://doaj.org/article/2227dff1010342dca908ce3c1a7fa500
Autor:
Olga E. Ivanova, Liubov I. Kozlovskaya, Tatiana P. Eremeeva, Armen K. Shakaryan, Alexander P. Ivanov, Olga Y. Baykova, Alexander Y. Krasota, Elena Y. Shustova, Aida N. Mustafina, Nadezhda S. Morozova, Makhtob S. Bobokhonova, Sergei E. Deshevoi, Aidar A. Ishmukhametov
Publikováno v:
International Journal of Infectious Diseases, Vol 125, Iss , Pp 35-41 (2022)
Objectives: The detection of a vaccine-derived poliovirus (VDPV) requires an epidemiological assessment and response. Using repeated stool sampling from a child who is immunocompetent and was vaccinated against poliomyelitis with acute flaccid paraly
Externí odkaz:
https://doaj.org/article/710e970dc4f34573ac229ce3ef28eca0
Autor:
Olga E. Ivanova, Tatiana P. Eremeeva, Nadezhda S. Morozova, Yulia M. Mikhailova, Liubov I. Kozlovskaya, Olga Y. Baikova, Armen K. Shakaryan, Alexandr Y. Krasota, Ekaterina A. Korotkova, Elizaveta V. Yakovchuk, Elena Y. Shustova, Alexander N. Lukashev
Publikováno v:
Viruses, Vol 16, Iss 1, p 135 (2024)
More than 100 types of non-polio enteroviruses (NPEVs) are ubiquitous in the human population and cause a variety of symptoms ranging from very mild to meningitis and acute flaccid paralysis (AFP). Much of the information regarding diverse pathogenic
Externí odkaz:
https://doaj.org/article/d34bbab00db84239b88bf994a0da1dc1
Autor:
Ilya V. Gordeychuk, Liubov I. Kozlovskaya, Aleksandra A. Siniugina, Nadezhda V. Yagovkina, Vladimir I. Kuzubov, Konstantin A. Zakharov, Viktor P. Volok, Maria S. Dodina, Larissa V. Gmyl, Natalya A. Korotina, Rostislav D. Theodorovich, Yulia I. Ulitina, Dmitry I. Vovk, Marina V. Alikova, Anna A. Kataeva, Anna V. Kalenskaya, Irina V. Solovjeva, Elena V. Tivanova, Larissa Y. Kondrasheva, Antonina A. Ploskireva, Vasiliy G. Akimkin, Ksenia A. Subbotina, Georgy M. Ignatyev, Anastasia K. Korduban, Elena Y. Shustova, Ekaterina O. Bayurova, Alla S. Zhitkevich, Daria V. Avdoshina, Anastasia N. Piniaeva, Anastasia A. Kovpak, Liliya P. Antonova, Yulia V. Rogova, Anna A. Shishova, Yury Y. Ivin, Svetlana E. Sotskova, Konstantin A. Chernov, Elena G. Ipatova, Ekaterina A. Korduban, Aydar A. Ishmukhametov
Publikováno v:
Viruses, Vol 15, Iss 9, p 1828 (2023)
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in volu
Externí odkaz:
https://doaj.org/article/888b158eaf434d709bf07e578aead9e6
Autor:
Nadezhda V. Yagovkina, Lev M. Zheleznov, Ksenia A. Subbotina, Andrey A. Tsaan, Liubov I. Kozlovskaya, Ilya V. Gordeychuk, Anastasia K. Korduban, Yury Y. Ivin, Anastasia A. Kovpak, Anastasia N. Piniaeva, Anna A. Shishova, Elena Y. Shustova, Yusuf K. Khapchaev, Galina G. Karganova, Alexandra A. Siniugina, Tatiana V. Pomaskina, Aleksandr A. Erovichenkov, Konstantin Chumakov, Aydar A. Ishmukhametov
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundEffective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could sign
Externí odkaz:
https://doaj.org/article/bbeca342ee3848b59babc5aa3a6847f5
Autor:
Olga E. Ivanova, Armen K. Shakaryan, Nadezhda S. Morozova, Yulia A. Vakulenko, Tatyana P. Eremeeva, Liubov I. Kozlovskaya, Olga Y. Baykova, Elena Y. Shustova, Yulia M. Mikhailova, Natalia I. Romanenkova, Nadezhda R. Rozaeva, Natela I. Dzhaparidze, Nadezhda A. Novikova, Vladimir V. Zverev, Lyudmila N. Golitsyna, Alexander N. Lukashev
Publikováno v:
Microorganisms, Vol 10, Iss 1, p 112 (2022)
Surveillance for acute flaccid paralysis syndrome (AFP) in children under 15 is the backbone of the Global Polio Eradication Initiative. Laboratory examination of stool samples from AFP cases allows the detection of, along with polioviruses, a variet
Externí odkaz:
https://doaj.org/article/7a6b79da45104de997b8fcdd162434df
Autor:
Dmitriy Y. Ryazantsev, Mikhail Yu. Myshkin, Vera A. Alferova, Vladimir B. Tsvetkov, Elena Y. Shustova, Polina N. Kamzeeva, Polina V. Kovalets, Elvira R. Zaitseva, Nadezhda S. Baleeva, Timofei S. Zatsepin, Zakhar O. Shenkarev, Mikhail S. Baranov, Liubov I. Kozlovskaya, Andrey V. Aralov
Publikováno v:
Biomolecules, Vol 11, Iss 10, p 1409 (2021)
Green fluorescent protein (GFP) chromophore and its congeners draw significant attention mostly for bioimaging purposes. In this work we probed these compounds as antiviral agents. We have chosen LTR-III DNA G4, the major G-quadruplex (G4) present in
Externí odkaz:
https://doaj.org/article/eb70196d328044b29c4c485a13dc27cf
Autor:
Andrey Kruglov, Marina Bondareva, Violetta S. Gogoleva, Iaroslav Semin, Irina Astrakhantseva, Ruslan Zvartsev, Aleksandr Lunin, Vasiliy Apolokhov, Elena Y. Shustova, Viktor Volok, Aleksey A. Ustyugov, Aydar A. Ishmukhametov, Sergei A. Nedospasov, Liubov Kozlovskaya, Marina Drutskaya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09ece4c594fd94306f7d2fd7f3c83968
https://doi.org/10.2139/ssrn.4430397
https://doi.org/10.2139/ssrn.4430397
Autor:
Elena S. Matyugina, Mikhail S. Novikov, Liubov I. Kozlovskaya, Victor P. Volok, Elena Y. Shustova, Aidar A. Ishmukhametov, Sergey N. Kochetkov, Anastasia L. Khandazhinskaya
Publikováno v:
Acta Naturae
The pandemic caused by the novel betacoronavirus SARS-CoV-2 has already claimed more than 3.5 million lives. Despite the development and use of anti-COVID-19 vaccines, the disease remains a major public health challenge throughout the world. Large-sc
Autor:
Aydar A Ishmukhametov, Aleksandra A Siniugina, Nadezhda V Yagovkina, Vladimir I Kuzubov, Konstantin A Zakharov, Viktor P Volok, Maria S Dodina, Larissa V Gmyl, Natalya A Korotina, Rostislav D Theodorovich, Yulia I Ulitina, Andrey A Tsaan, Tatiana V Pomaskina, Anna V Kalenskaya, Irina V Solovjeva, Elena V Tivanova, Larissa Y Kondrasheva, Antonina A Ploskireva, Vasiliy G Akimkin, Ksenia A Subbotina, Georgy M Ignatyev, Anastasia K Korduban, Elena Y Shustova, Ekaterina O Bayurova, Alla S Kondrashova, Darya V Avdoshina, Anastasia N Piniaeva, Anastasia A Kovpak, Liliya P Antonova, Yulia V Rogova, Anna A Shishova, Yury Y Ivin, Svetlana E Sotskova, Konstantin A Chernov, Elena G Ipatova, Ekaterina A Korduban, Liubov I Kozlovskaya, Ilya V Gordeychuk
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in adult volunteer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa7f5e2e5807fe5981592d7795102a1
https://doi.org/10.1101/2022.02.08.22270658
https://doi.org/10.1101/2022.02.08.22270658